Variant report
Variant | esv2398826 |
---|---|
Chromosome Location | chr8:50009014-50009504 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:50006800..50008317-chr8:50008393..50010023,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs12546839 | chr8:50009020-50009021 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs541495990 | chr8:50009047-50009048 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560390821 | chr8:50009053-50009054 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182675068 | chr8:50009089-50009090 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs76434040 | chr8:50009142-50009143 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs564209958 | chr8:50009159-50009160 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs370331731 | chr8:50009189-50009190 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs531366241 | chr8:50009191-50009192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549510681 | chr8:50009192-50009193 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs567858341 | chr8:50009195-50009196 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7821013 | chr8:50009243-50009244 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs186999120 | chr8:50009253-50009254 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs202102820 | chr8:50009313-50009314 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539627631 | chr8:50009330-50009331 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs558449503 | chr8:50009331-50009332 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570246879 | chr8:50009332-50009333 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537494051 | chr8:50009333-50009334 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs555806205 | chr8:50009334-50009335 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs191457490 | chr8:50009361-50009362 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs541559077 | chr8:50009441-50009442 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs78692631 | chr8:50009463-50009464 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs572240538 | chr8:50009499-50009500 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Lung cancer | 18438408 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Melanoma | 17363583 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Sezary syndrome | 18413736 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:50005200-50009200 | Weak transcription | H1 Cell Line | embryonic stem cell |
2 | chr8:50008200-50015400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
3 | chr8:50008200-50015600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr8:50009000-50010000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
5 | chr8:50009200-50010000 | Enhancers | H1 Cell Line | embryonic stem cell |
6 | chr8:50009200-50010200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |